AEON.WS
AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share
AEON.WS
AEON.WS
Delisted
AEON.WS was delisted on the 26th of April, 2024.
49 hedge funds and large institutions have $2.87M invested in AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-3
Holders Change %
-5.77%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
2
Closed
10
Calls
$352K
Puts
–
Net Calls
+$352K
Net Calls Change
-$662K
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GPCM
51
Granite Point Capital Management
Boston,
Massachusetts
| – | -$2K | -66,666 | Closed |
|
|
RA
52
Ramius Advisors
New York
| – | -$3K | -65,792 | Closed |
|
53
Citadel Advisors
Miami,
Florida
| – | -$2.7K | -59,281 | Closed |
|
|
FIG
54
Fortress Investment Group
New York
| – | -$2.1K | -46,138 | Closed |
|
|
OMC
55
Old Mission Capital
Chicago,
Illinois
| – | -$734 | -16,118 | Closed |
|
|
TAM
56
Terrapin Asset Management
Miami,
Florida
| – | -$304 | -6,666 | Closed |
|
|
6CM
57
683 Capital Management
New York
| – | -$152 | -3,333 | Closed |
|
58
UBS Group
Zurich,
Switzerland
| – | -$65 | -1,300 | Closed |
|